Neuronetics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Neuronetics, Inc. (STIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 0.40% for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-07.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2023-03-07
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 0.90%, a 64.00% decline year-over-year.
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.50%.
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.40%, a 81.82% decline from fiscal 2019.
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 2.20%, a 18.52% decline from fiscal 2018.
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.70%, a 35.00% increase from fiscal 2017.
- Neuronetics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 2.00%, a 42.86% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2020-12-31 | 0.40% 10-K · filed 2023-03-07 | |||
| 2020-09-30 | 0.38% 10-Q · filed 2020-11-02 | |||
| 2020-06-30 | 1.00% 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | 0.90% 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | 2.20% 10-K · filed 2022-03-08 | |||
| 2019-09-30 | 2.30% 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | 2.40% 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | 2.50% 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | 2.70% 10-K · filed 2021-03-02 | |||
| 2018-09-30 | 2.70% 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | 2.70% 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | 2.00% 10-K · filed 2020-03-03 | |||
| 2016-12-31 | 1.40% 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |